Course for Interventionist in training 2014.

ProEducar-SOLACI course presentations concluded on April 22, 2014 in Buenos Aires, Argentina

The V Edition of the “José Gabay” course of ProEducar – SOLACI,  be held as pre-conference activity at SOLACI, is aimed for interventionists in training all over America with the intention of strengthening the existing educational programs and, as well, provide a forum for them to integrate. // Read programe

More articles by this author

See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition...

The best images of the 13th ProEducar Fellows Course at SOLACI-SBHCI 2023

Relive the best images of the 13th ProEducar Fellows Course held on August 2 during the SOLACI-SBHCI 2023 Congress in the URCA Room of...

13th ProEducar-SOLACI Fellows Course Held at SOLACI-SBHCI 2023

ProEducar-SOLACI Fellows Course continues to grow! For the thirteenth consecutive year, the traditional SOLACI course for fellow interventionists was held at SOLACI-SBHCI 2023. The course...

Teve lugar o 13º Curso de Fellows do ProEducar-SOLACI no Congresso SOLACI-SBHCI 2023

o Curso de Fellows do ProEducar-SOLACI continua crescendo! Pelo décimo terceiro ano consecutivo teve lugar o tradicional Curso da SOLACI para intervencionistas em formação...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...